Invention Grant
US09051326B2 Pyrazoline derivatives and their use as selective androgen receptor modulators
有权
吡唑啉衍生物及其作为选择性雄激素受体调节剂的用途
- Patent Title: Pyrazoline derivatives and their use as selective androgen receptor modulators
- Patent Title (中): 吡唑啉衍生物及其作为选择性雄激素受体调节剂的用途
-
Application No.: US14234599Application Date: 2012-07-25
-
Publication No.: US09051326B2Publication Date: 2015-06-09
- Inventor: Mark Gary Bock , Bharat Lagu , Chetan Pandit , Sanjita Sasmal , Thomas Ullrich
- Applicant: Mark Gary Bock , Bharat Lagu , Chetan Pandit , Sanjita Sasmal , Thomas Ullrich
- Applicant Address: CH Basel
- Assignee: NOVARTIS AG
- Current Assignee: NOVARTIS AG
- Current Assignee Address: CH Basel
- Agent John B. Alexander
- Priority: IN2140/DEL/2011 20110727
- International Application: PCT/IB2012/053795 WO 20120725
- International Announcement: WO2013/014627 WO 20130131
- Main IPC: A61K31/415
- IPC: A61K31/415 ; A61K31/4162 ; C07D231/54 ; C07D487/04
Abstract:
The invention relates to a compound of formula (I) in free form or in pharmaceutically acceptable salt form (I), in which the substituents are as defined in the specification; to compounds of formula (I) for use as androgen receptor modulators. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
Public/Granted literature
- US20140329876A1 PYRAZOLINE DERIVATIVES AND THEIR USE AS SELECTIVE ANDROGEN RECEPTOR MODULATORS Public/Granted day:2014-11-06
Information query
